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CHAPTER I 
INTRODUCTION 
Translational control is exerted predominantly at the initiation step in eukaryotic 
cells. Regulatory control in these cells is mediated by specific alterations in the 
activities of key initiation factors (1, 2, 3, 4). The best characterized regulatory 
process involve the three subunits (a = 38 kDa, p = 36 kDa, y = 56 kDa) of 
eukaryotic initiation factor-2 (eIF-2). eIF-2 is the initiation factor involved in the 
formation of a ternary complex that includes met-tRNAi, elF-2 and GTP (5, 6). This 
ternary complex facilitates the positioning of the met-tRNAi on the 40S ribosomal 
subunit to form the 43S initiation complex (7, 8). Once formed, the 43S initiation 
complex binds to eukaryotic mRNA complexes containing eIF-4F, eIF-4A, and eIF-
4B in a ATP dependent reaction and scans to the first AUG sequence to form the 
48S initiation complex. eIF-5 catalyzes the hydrolysis of eIF-2 bound GTP, causing 
the release of eIFs from the 48S initiation complex and the binding of the 48S 
initiation complex to the 60S ribosomal subunit to form the 80S initiation complex. 
The formation of this 80S initiation complex completes eukaryotic translational 
initiation (9, 10). Ternary complex formation is believed to be the committed step 
in eukaryotic translational initiation, so regulation of its formation is expected to 
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play a key role in the overall control of protein synthesis. Such appears to be the 
case and central to this control is the phosphorylation of the a-subunit of eIF-2 by 
specific kinases ( 4, 11 ). 
This regulation has been most extensively studied in the reticulocyte lysate 
system, which contains two kinases specific for the a-subunit of eIF-2 (eIF-2a). 
The heme-regulated eIF-2a kinase (HRI) becomes activated in response to hemin 
deficiency, addition of oxidized glutathione, heavy metals, and heat shock (11, 12, 
13, 14). The double-stranded RNA activated inhibitor (DAI) is activated by low 
concentrations of double-stranded RNA (15, 16). Activation of either of these 
kinases results in the phosphorylation of eIF-2a, followed by distintegration of 
polysomes and termination of protein synthesis. Termination of protein synthesis is 
caused by the inability of the lysate to regenerate functional eIF-2. 
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Upon joining of the 48S initiation complex with the 60S ribosomal subunit to 
form the 80S initiation complex, GTP is hydrolysed with subsequent release of eIF-2 
in a binary complex with GDP (10, 17). eIF-2/GDP is nonfunctional in translational 
initiation, so the reutilization of eIF-2 in subsequent rounds of initiation requires 
replacement of bound GDP with GTP. At physiological concentration of Mg2+, eIF-
2 has a 400 fold higher affinity for GDP than GTP and the GDP is bound so tightly 
that it effectively does not dissociate from eIF-2 (18). The exchange of GTP for 
GDP thus requires the participation of another initiation factor. 
The factor with this exchange activity is the five-subunit ( a = 26 kDa, P = 40 
kDa, y = 58 kDa, 8 = 68 kDa, s = 82 kDa) eukaryotic initiation factor-2B (eIF-2B), 
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also known as reversing factor (RF) or guanine nucleotide exchange factor (GEF) 
(19, 20, 21). The termination of protein synthesis upon phosphorylation of eIF-2a is 
due to the loss of eIF-2B activity. The loss of eIF-2B exchange activity most likely 
is the result of formation of a stable nonfunctional complex of eIF-2B with 
phosphorylated eIF-2 (22). Since eIF-2 is about 15 fold more abundant than eIF-2B 
in reticulocyte lysate, formation of this nonfunctional complex results in 
sequesteration of the low abundance eIF-2B and a termination of protein synthesis. 
Although regulation of protein synthesis has been extensively documented in 
reticulocyte lysates, analogous studies with nonerythoid cells indicates that this may 
be a general mechanism by which eIF-2 phosphorylation (via alteration of eIF-2B 
activity) regulates protein synthesis in all eukaryotic cells. 
While a regulatory role for eIF-2B in protein synthesis has been established, its 
reaction mechanism, mode of interaction with eIF-2 and the specific roles of its 
subunits remains largely unknown. Indeed the cellular concentration of eIF-2B, 
upon which the current hypothesis of the control of protein synthesis by eIF-2 
phosphorylation is based, remains to be conclusively established. In addition, the 
role of the phosphorylation of the 82 kDa subunit of eIF-2B (eIF-2BE) in the control 
of eIF-2B activity remains to be determined. In order to begin to dissect the 
structure and function of eIF-2B, the present study is designed to clone and sequence 
the complementary DNA (cDNA) to its 82 kDa subunit. Information obtained from 
the cDNA sequence will provide the amino acid sequence of this subunit, thus 
providing a means of generating antibodies against it. The availability of such 
antibodies will enable the characterization of the cellular concentration of e1F-2B 
and the role of phosphorylation of eIF-2BE in the control of eIF-2B activity. 
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CHAPTER II 
LITERATURE REVIEW 
Properties of eIF-2B 
eIF-2B is a nonribosomal associated initiation factor that plays a key regulatory 
role in eukaryotic protein synthesis. It has been purified from different sources to 
apparent homogenity either as complex with elF-2 or as free eIF-2B, as judged by 
SOS polacryamide gel electrophoresis (SOS-PAGE) followed by Coomassie blue or 
silver staining (19, 23, 24, 25, 26). From all sources, eIF-2B preparations show 
similar subunit composition. Slight variations in the molecular weight of the 
subunits of eIF-2B are observed in some cases. All five subunits appear to be 
present in equal molar amounts, although the 58 kDa subunit appears to be less 
abundant. The difference in the stoichemistry of the 58 kDa subunit has been 
attributed to its susceptibilty to proteolysis. Purified eIF-2B has an apparent 
molecular weight of approximately 250 kDa as determined by its sedimentation rate 
during centrifigation in sucrose density gradient. eIF-2B forms a tight complex of 
about 450 kDa with eIF-2 that is dissociable by high salt concentration (19). 
Although nonribosomal associated, eIF-2B has been shown to interact transciently 
with the 60S ribosomal subunit. It has been proposed that eIF-2B mediates the 
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guanine nucleotide exchange reaction with eIF-2 on this ribosomal subunit (21, 22). 
eIF-2B has also been shown to be a phosphoprotein, phosporylated on its 82 and 67 
kDa subunits. Phosphorylation on the 82 kDa subunit is mediated by casein kinase 
II (27) while the 67 kDa subunit is phosphorylated by a mechanism which is 
predicted to involve autophosphorylation (6). Using photoaffinity labeling with 8-
azidoadenosine-5-phosphate Dholakia, et al. (28), have demonstrated that the 58 and 
67 kDa subunits of eIF-2B binds ATP. The binding of ATP to these subunits 
appears consistent with autophosphorylation. This proposition, however, remains 
speculative and requires more detailed analysis. In addition to labeling with 8-azido 
ATP, eIF-2B is also labeled with 8-azidoguanine-5-phosphate on its 40 kDa subunit 
indicating that it may also be a guanine nucleotide binding protein. At high 
concentrations, eIF-2B also binds 2 moles of NADPH per molecule (23). The 
interaction of eIF-2B with NADPH is stablized by the presence of DTT and 
glycerol, but the full implication of this association with respect to its activity in 
vivo has not been demonstrated. 
Regulation of eIF-2B Activity 
The primary means by which eIF-2B activity is regulated is by phosphorylation 
of eIF-2a (11). This phosphorylation results in the formation of a tight complex 
with eIF-2B that sediments with a sedimentation coefficient of 15S on glycerol 
gradient centrifugation (22). GDP is freely dissociable from this complex, but the 
eIF-2B in this complex is unavailable to catalyze the exchange reaction, because it 
cannot freely dissociate from phosphorylated eIF-2. The ~ of eIF-2(aP) for eIF-2B 
is approximately 0.29 run, so this inhibition is essentially irreversible and eIF-2B is 
effectively sequestered (41). eIF-2B can be released from this complex with 
consequent restoration of protein synthesis by phosphatase treatment, but it is 
unclear which cellular phosphatase may catalyse the reaction (22). 
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Since the sequesteration of eIF-2B in a complex with eIF-2(aP) and subsequent 
inhibition of its activity results in termination of protein synthesis, the inhibition of 
protein synthesis observed when eIF-2 is phosphorylated is only physiologically 
relevant, if the cellular concentration of eIF-2 exceeds that of eIF-2B. Indeed in 
reticulocyte lysates, eIF-2 is estimated to be 15 fold more abundant than eIF-2B and 
the phosphorylation of only 30% of the eIF-2 results in almost a 90% reduction in 
protein synthesis (20, 29, 30). In Ehrlich ascites tumor cells, the ratio of eIF-2 to 
eIF-2B is approximately two to one and phosphorylation of 50% of eIF-2 results in 
a considerable reduction in protein synthesis (31 ). In T lympocytes the levels of 
eIF-2B and eIF-2(aP) are also similar, but upon activation by mitogens, the 
observed increase in protein synthesis coincides with an increase in the 
synthesis/activity of eIF-2B with no corresponding increase in phosphorylation of 
eIF-2 (34). Thus, although the cellular concentrations of eIF-2B in other cell types 
has yet to be determined, it seems likely that differences in the relative abundance of 
eIF-2 and eIF-2B may be common to all cells. 
As a major regulatory protein in protein synthesis, the activity of eIF-2B is also 
regulated by cellular nutrients, redox state and growth requirements of the cell. The 
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first indication of the regulatory influence of a cellular nutrient came from the work 
of Ersnt, et al (12). Using gel filtered reticulocyte lysates, they demonstrated that 
glucose-6-phosphate prevents or reverses the inhibition of protein synthesis due to 
activation of HRI by hemin deficiency and oxidized glutathione. Glucose-6-
phosphate (G-6-P) is also required as a stimulatory factor for initiation, an effect 
which is independent of its role as a metabolite. This effect of G-6-P has been 
proposed to be exerted on the activity of eIF-2B (35). It is postulated that G-6-P 
may act as an effector that directly stimulates eIF-2B activity. This may account for 
the observed ability of insulin to stimulate eIF-2B activity in rat fast twitch fibre 
(36). In these cells, insulin deficiency does not lead to an increase in eIF-2a 
phosphorylation (71), but the activity of eIF-2B is reduced up to 80%. It is possible 
that during insulin deficiency, the limited availability of G-6-P leads to a reduction 
in eIF-2B activity. 
G-6-P may also have indirect effects on eIF-2B activity, since it is required for 
NADPH production. Wabha et al (23) have recently demonstrated that eIF-2B binds 
NADPH and that this association stimulates eIF-2B activity. Consistent with a role 
for NADPH in eIF-2B activation is the observed increase in eIF-2B activity upon 
fertilization of sea urchin eggs; this process is accompanied by an increase in the 
concentration of NADPH (33). Although the exact role of NADPH in regulating 
eIF-2B activity is not known, it has been suggested that it may be required for the 
maintenance of its structural integrity, since eIF-2B preparations retain their activity 
until subjected to repeated freezing and thawing or prolonged storage (25). 
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The activity of eIF-2B is also modulated by the availability of amino acids. In 
reticulocyte lysate, amino acid deficiency leads to a 50% reduction in the activity of 
eIF-2B, but no change in e1F-2a. phosphorylation is observed (37). The 
corresponding reduction in protein synthesis is due to a decrease in polypeptide 
chain elongation. In nonerythoid cells, however, amino acid deficiency leads to the 
inhibition of protein synthesis initiation via increased phosphorylation of eIF-2a. and 
a consequent reduction in eIF-2B activity. Chinese Hamster ovary cells with a 
temperature sensitive leucyl-tRNA synthetase activity mimic the effect of amino acid 
deficiency at non permissive temperatures (39, 40). It is possible that the mutation 
in leucyl-tRNA synthetase leads to accumulation of uncharged tRNA,eu, which may 
activate a kinase that phosphorylates eIF-2a.. The inhibition of protein synthesis 
initiation that results from amino acid deficiency would then be analogous to GCN4 
regulation in yeast where accumulation of uncharged tRNAhis has been proposed to 
be the signal which activates the GCN2 kinase (52). 
Polyamines also regulate the activity of eIF-2B (37). Their depletion in 
reticulocyte lysate, by gel filtration results in a 35% reduction in the activity of eIF-
2B and a corresponding 70% reduction in the rate of protein synthesis. The 
reduction in protein synthesis is due to inhibition of initiation of protein synthesis, 
resulting from a reduction in the activity of eIF-2B. The precise mechanism by 
which polyamines mediate their effect on eIF-2B activity is unclear. One possible 
explanation is that polyamines regulate casein kinase II ( 42) and this in turn alters 
the phosphorylation state of eIF-2B. Dholakia and Wahba (27) have demonstrated 
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in a recent study that phosphorylation of eIF-2BE by casein kinase II results in a 2.5 
fold increase in eIF-2B activity, and that dephosphorylation of the subunit by 
treatment with alkaline phosphatase results in a five fold reduction of its activity. 
The five-fold reduction in eIF-2B activity on dephosphorylation does not, however, 
account for the 35% reduction in the activity of eIF-2B upon depletion of 
· polyamines. 
Mechanism of eIF-2B Catalyzed Guanine Nucleotide Exchange Reaction 
While the role of eIF-2B in the control of protein synthesis in eukaryotic cells is 
generally agreed on, the mechanism of the reaction it catalyzes remains 
controversial. eIF-2B catalyzes the two substrate reaction represented below, so its 
reaction is 
eIF-2/GDP + GTP --------> eIF/GTP + GDP 
expected to follow either sequential or a substituted (ping pong) enzyme mechanism. 
Both mechanisms have been proposed for this reaction by different groups. Using 
measurements of the fluroscence anisotropy effect of eIF-2B's interaction with 
dansylated eIF-2, and a filtration assay which measures the binding of radiolabeled 
GDP or GTP to eIF-2, Goss et. al. (43) proposed a substituted mechanism for the 
eIF-2B catalyzed reaction. In their propsed mechanism, eIF-2B binds to the binary 
complex eIF-2/GDP to form eIF-2/GDP/eIF-2B. GTP then displaces eIF-2B and 
GDP from this ternary complex with the formation of eIF-2/GTP. In another study, 
Rowland et al, (41) used results of the kinetic analysis of the eIF-2B reaction to also 
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propose a ping pong mechanism. In their proposed mechanism, the binding of eIF-
2B to eIF/GDP causes the displacement of the bound GDP to form a eIF-2/eIF-2B 
complex. GTP then displaces free eIF-2B from this complex regenerating the 
functional eIF-2. This mechanism differs slightly from the mechanism of Ochoa et. 
al. (44), who proposed that following the formation of the eIF-2/eIF-2B/GTP 
complex, met-tRNAi binds to form a quaternary complex. Free eIF-2B is then 
released upon binding of the quaternary complex to the 40S rRNA. Recently, 
Dholakia et. al. (45) have demonstrated that eIF-2B is a G-binding protein, and this 
finding has lead them to propose a sequential mechanism for the eIF-2B catalyzed 
reaction. In the sequential model, the substates eIF-2/GDP and GTP bind to eIF-2B 
to form a quaternary complex. The exchange reaction by implication then takes 
place in this complex with the release of the products eIF-2/GTP and GDP. Their 
study did not demonstrate however whether the eIF-2B exchange reaction followed 
an ordered or a random sequential mechanism. 
eIF-2B in Yeast 
The development of a cell free translation system from reticulocyte lysates has 
facilitated the detailed study of protein synthesis in mammalian cells. Recently, an 
in vitro translation system has been developed from the yeast Saccharomyces 
cerevisae ( 46). The availability of this system, coupled with the ability to perform 
genetic manipulation is beginning to yield information on the regulation of protein 
synthesis in lower eukaryotes (47). Similar to that found in the mammalian system, 
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protein synthesis in yeast is also regulated at the initiation step. Much of the 
supporting information comes from the study of the control of amino acid 
biosynthesis in yeast ( 48). In yeast, amino acid deficiency leads to the activation of 
several genes encoding the enzymes required for amino acid biosynthesis ( 49). The 
activation of these genes is mediated by the transcription activator GCN4. When 
yeast cells have adequate supply of amino acid the synthesis of GCN4 is repressed, 
but amino acid starvation results in a derepression of GCN4 synthesis. 
Regulation of GCN4 is exerted at the translational level. Studies in yeast strains 
with defects in GCN4 regulation indicate that this control is mediated at the 
initiation step by modulation of the interactions between some initiation factors and 
regulatory elements in the 5' leader sequence of the GCN4 mRNA (48, 50, 51, 55). 
Similar to the regulation of translation in mammalian system, eIF-2 appears to play a 
major role in the regulation of GCN4 expression and yeast protein synthesis in 
general. Genetic studies have indicated that the a. and B subunits of yeast eIF-2, are 
negative regulators of GCN4. In addition, GCN2 a positive regulator of GCN4, has 
been shown to be a protein kinase, specific for eIF-2a.. The GCN2 protein has 
extensive sequence similarity to mammalian DAI and HRI (72). The N-terminal 
domain of GCN2 has significant homology to his-tRNA aminoacyl synthetase. It 
has been proposed that amino acid starvation leads to accumulation of uncharged 
tRNAhis , which binds to GCN2 and activates its kinase activity. Based on these 
findings, Dever et. al. (54), have proposed that the derepression of GCN4 upon 
amino acid starvation results from increased phosphorylation of eIF-2a. by GCN2. 
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The increase in phosphorylation is believed to impair the assembly of functional 
initiating ribosomes, which leads to a reduced level of reinitiation at upstream AUG 
codons in the regulatory leader sequence, thus facilitating initiation at the proper 
GCN4 AUG start site. 
In mammalian cells, phosphorylation of eIF-2a impairs the exchange reaction 
catalyzed by eIF-2B, so eIF-2B is expected to play a role in this eIF-2 mediated 
control of GCN4 expression and the overall regulation of yeast protein synthesis. 
Although the yeast equivalent of eIF-2B has not been isolated, available information 
indicates that yeast GCD genes and GCN3 may code for the subunits of eIF-2B. 
The GCD genes are negative regulators of GCN4 expression and deletion of any of 
the genes leads to unconditional lethality in yeast, suggesting an essential role (56, 
57). The essential role of the GCD gene products appears to involve their 
requirement for translational initiation, since temperature sensitive mutants of these 
genes show a depletion of the 43S initiation complex and polyribsome disintegration, 
two conditions characteristic of defects in translational initiation (58). 
Biochemical studies also support a role for these genes in protein synthesis 
initiation and indicate that their gene products may be the yeast analog of eIF-2B. 
Cigan et. al. (59) haved shown that antibodies directed against GCDl or GCD2 co-
immunoprecipitate GCD 1, GCD2 and GCN3 suggesting that the three proteins are 
associated with each other. Furthermore, these proteins coelute from a Sephacryl S-
300, and much like the mammalian eIF-2/eIF-2B complex, they co-sediment with 
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eIF-2 as a high molecular weight complex of approximately 600 kDa during sucrose 
density gradient centrifugation. eIF-2 can be dissassociated from the complex in the 
presence of high salt, but GCDl, GCD2, and GCN3 still co-sediment together, 
further indicating that they are part of the same complex. 
Other Functions of eIF-2B 
Although the exchange activity of eIF-2B is its most extensively studied 
function, available data suggests that eIF-2B may have additional functions. eIF-2B 
has been shown to bind ATP, however, the binding of this nucleotide has not been 
found to have any functional effect on the exchange activity of eIF-2B. Thus, in 
addition to a potential regulatory role, this nucleotide may be involved in an 
unidentified function of eIF-2B. In a recent study, Van Heugter et. al. (60), have 
shown that eIF-2/eIF-2B binds to mRNA cap via the p and a subunits of eIF-2. The 
efficiency of this interaction is greatly reduced in the absence of eIF-2B, suggesting 
that it plays a role in the cap binding. Moreover, an unidentified 40 kDa protein 
also crosslinked to the cap, this protein is probably the p subunit of eIF-2B, since 
eIF-2 does not have a subunit of this molecular weight. Further studies on the fate 
of this protein in the absence of eIF-2B in the crosslinking reaction will be required 
to determine if eIF-2B plays a direct role in cap binding of the complex. 
CHAPTER III 
MATERIALS AND METHODS 
Materials 
The synthetic oligodeoxyribonucleotide primers used for sequencing were 
synthesized by Oligos et. al. and National Bioscience. Sequencing reactions were 
performed with reagents in the Sequenase sequencing kit from United States 
Biochemical Corporation (USB, Cleveland Ohio). Sequencing gels were cast with 
USB ultrapure reagents. The radioactive materials [ a 32P] CTP, [ a 35S] ATP 
(sequencing grade), and 35S-methionine were purchased from Dupont/New England 
Nuclear. The n-( 4-azido-2-nitrophenyl)-n-(3-biotinyl-aminopropyl)-n-methyl-1, 3-
propanediamine (photobiotin) used for labeling the probe for nonradioactive 
hybridization was from Sigma. The photogene nucleic acid detection kit and 
biotinylated lambda DNA (Hind III fragments) were from GIBCOBRL 
(Gaithersburg, MD). Nitrocellulose membranes (150mm and 100mm circles) used 
for antibody screening and Western blotting were obtained from Millipore. 
Photogene Nylon membrane used for Northern blotting and nucleotide screening 
were purchased from GIBCOBRL. The restriction enzyme PpuMI was obtained 
from United States Biochemicals and all other enzymes were from GIBCOBRL or 
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Promega. The affinity purified alkaline phosphatase linked Rabbit anti-chicken IgG 
was purchased from USB. Rabbit reticulocytes used for RNA isolation was from 
Green Hectares (Oregon, WI). The nuclease free reticulocyte lysate used for in vitro 
translation was purchased from Ambion Inc (Austin, TX). The E. coli strain XL-1-
Blue was from Stratagene (LaJolla, California). All other reagents were molecular 
biology reagent grade. 
Methods 
Isolation of the cDNA Encoding eIF-2BE 
The cDNA encoding e1F-2BE was isolated by screening a rabbit reticulocyte 
lysate A-ZAP library, supplied by Dr. J. J. Chen, (M. I. T) with a polyclonal 
antibody raised against all the five subunits of eIF-2B. 337,500 recombinant phage 
were grown on a lawn of XL-1-Blue for 3.5 hours at 42 °C at a density of 37,500 pfu 
per 150 mm plate. Plates were overlayed with 120 mm nitrocelluse filters 
previously saturated with 10 mM IPTG and incubation was continued for an 
additional 4 hours at 37°C. Because the rabbit anti-chicken IgG cross reacts with a 
26 kDa protein in reticulocyte lysates, a second filter was overlayed on the plates 
and incubated for an additional 3.5 hours. Next nitrocelluse filters were incubated 
with a blocking solution containing 10% calf fetal serum in TBS (50 mM Tris/HCl 
(pH 7.5), 150 mM NaCl) for two hours. Following incubation with the blocking 
solution, one set of the filters was incubated overnight at 4 ° C with a 100 fold 
dilution of the eIF-2B antibody preabsorbed with E. coli/phage extract. The filters 
were washed with TBST (TBS, 0.05% Tween 20) three times at room temperature. 
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A replicate set of filters were left overnight in the blocking solution and then washed 
three times with TBST. Next the filters were incubated with a 4000 fold dilution of 
alkaline phosphatase-linked Rabbit anti-chicken lgG (15 ml/filter) for one hour at 
room temperature. Positive clones were detected by incubation with 10 µg NBT and 
167 µg BCIP in a 30 ml buffer containing 100 mM Tris/HCl (pH 9.5), 100 mM 
NaCl, and 5 mM MgC12 at room temperature for approxi!Ilately 5 minutes. Clones 
with positive signals on both filters were discarded as false positives. One positive 
phage (A-pAl) was isolated and plaque purified by sequential screening at low phage 
density. The corresponding cDNA of the positive clone was subcloned into 
pBluescript in vivo by infecting XL-I-Blue with A-pAl and the helper phage R408, 
followed by overnight incubation on an ampicilin LB agar plate at 37°C as described 
in Stratagene manual. The resulting plasmid with the cDNA insert (pAl) was 
subjected to restriction endonuclease and nucleotide sequence analysis. 
Because the putative nucleotide sequence of pAl lacked an immediate upstream 
AUG sequence,(see following section for sequence analysis) a 1068 bp probe 
(P1068) was amplified using PCR from the insert and used to rescreen the A-ZAP 
reticulocyte library. As with antibody screening, recombinant phage were grown on 
a lawn of XL- I-Blue overnight at 3 7 ° C. The plates were incubated at 4 ° C for two 
hours and overlayed with duplicate nylon filters. Bound phage DNA were denatured 
and cross linked to the nylon filters using Stratagene stratalinker. The filters were 
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hybridized to PI068 at high stingency in a hybridization buffer containing 50 ng/ml 
of biotinylated PI068, 50% formamide, 900 mM NaCl, 60 mM NaH2P04 (pH 7.4), 6 
mM EDTA, 0.1% ficoll, 0.1% polyvinylpymolidone, 0.1% BSA, 1% SDS, 100 µg 
sheared denatured salmon sperm DNA, and 10% dextran sulfate overnight at 42 ° C. 
Following hybridization, duplicate filters were washed twice at 65 ° C with 5 x SSC; 
(150 mM NaCl, 15 mM sodium citrate pH 7.0) containing 0.5% SDS for 15 min and 
once at 60 ° C with 0.1 x SSC containing 1 % SDS for 30 min. The filters were then 
incubated with alkaline phosphatase-linked streptavidin (1.0 µg/ml) for 15 mins at 
room temperature and positive clones were detected by incubation of the filters with 
4-methoxy-4-(3-phosphatephenyl) spiro [1,2-dioxoethane-3, 3-adamantene] at room 
temperature for three hours and followed by autoradiography. Clones giving 
positive signals on both filters were isolated, and the corresponding cDNA subcloned 
into pBluescript and subjected to restriction endonuclease restriction analysis and 
DNA sequence analysis. 
PCR Amplification, Biotinylation and Radiolabeling of PI068 
Two primers (P6 sense strand and PIO anti-sense strand) spanning 1068 bp of 
pAl were synthesized and used to amplify PI068 sequences. The amplified 
sequence extended from nucleotide 931 to 2000 on the sense strand of pAl. 1 ng of 
pAl was amplified with 2.5 U of ampliTaq DNA polymerase and 20 µM of each 
primers in a 100 µ1 reaction volume. The reaction conditions were 94 ° C for two 
minutes, 5 5 ° C for one minute, 72 ° C for three minutes. This cycle was repeated 40 
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times followed by a 10 minute final extension at 72 ° C. The amplified product was 
purified by phenol/chloroform extraction followed by ethanol precipitation. For 
biotinylation, 6 µg of purified P1068 and 25 µg photobiotin were photolyzed with a 
500 volt white light source in 50 µ1 reaction volume on ice for 20 minutes. The 
unreacted photobiotin was removed by chromotography on Bio-gel P60. P1068 was 
radiolabeled to a specific activity of 6.2 x 108 µCi/µg by random priming with 
Kienow. 50 ng of heat denatured P1068 was incubated for three hours at room 
temperature with 2.5U Kienow in a 25 µ1 reaction buffer containing 100 µCi [a32p] 
CTP, 10 mg BSA, 50 µmM ATP, GTP, and TTP. Following the incubation, 
unreacted radionucleotide was removed by spin column chromatography on 
Sephadex G-50. 
Expression of pAl in E.coli 
XL-I-Blue harboring pAl, was grown to mid log phase (A600 of approximately 
0.20) in 30 ml LB broth at 37°C and expression of the fusion protein was induced 
by addition of IPTG to a final concentration of 10 mM. Incubation was continued 
until the absorption at 600 nm for the cells was 1.0 OD/ml. The cells were pelleted 
by centrifugation at 6000g for 15 minutes, and resuspended in 7.5 ml of lysis buffer 
(50 mM Tris/HCI (pH 8.0), 1 mM EDTA, 1 mM PMFS, 10% sucrose, and 1 mg/ml 
lysozyme) and incubated on ice for 10 minutes. Triton X-100 was added to a final 
concentration of 0.1 % and incubation was continued for an additional 10 minutes. 
Following incubation with Triton X-100, cell debris was removed by centrifugation 
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at 12,000 rpm for 90 minutes. 30 µl of the clarified supernatant was electrophoresed 
on a 10% SDS-PAGE gel, stained with Coomassie blue staining, or immunoblotted. 
Sequence Analysis of pAl cDNA 
The nucleotide sequence of the isolated cDNA was determined by the 
dideoxynucleotide chain termination method (73). Double stranded DNA was 
sequenced completely using the sequenase kit (USB) and overlapping 
oligonucleotide primers made from sequences complementary to previously 
sequenced regions. The sequencing strategy is summarized in Figure 1. The first 
200 nucleotides 5' of the clone was very GC rich, so to remove sequence 
compression and band artifacts, this region was sequenced using double stranded 
DNA and dITP, with addition of 2 U of terminal deoxynucleotidyl transferase (TdT) 
to the sequence reactions after the dideoxy nucleotide termination ( ddNTP) step, as 
described by Fawcett et. al. (61). Addition of TdT extends sequences not terminated 
by incorporation of ddNTP, thus eliminating the band artifacts resulting from their 
presence on sequencing gels. As an additional check, this region was also 
sequenced from single stranded DNA. The nucleotide sequence of the pAl cDNA 
was analyzed using the Macvector sequence analysis programs (IBI). Sequence 
homology of the pAl cDNA and putative amino acids sequence to other protein was 
determined by searching GenBank using the Fasta program of Pearson and Lipman 
(62) and the NBRF data bank, respectively. 
Figure 1. Sequencing Strategy of pAl cDNA. 
Oligo nucleotide primers (18 to 22 nucleotides long) were synthesized and used as 
primers iri the sequencing reaction. Overlapping sequence were identified using 
the computer program DNA strider. 
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In Vitro Transcription and Translation of pAl cDNA 
pAl DNA was purified by double banding on cesium chloride gradient 
centrifugation. Following purification, 10 µg of pAl was extracted with 
phenol/CHC13 and linearized with 20U of EcoRV, followed by ethanol precipitation 
in the presence of IM NH40Ac. For the transcription reaction 3 µg of linearized 
pAl was incubated with 50 U T3 RNA polymerase in a 50 µl reaction buffer 
containing 40 mM Tris/HCl (pH 7.5), 50 mM NaCl, 8 mM MgCl, 2 mM 
spermidine, 0.6 mM r(UTP, CTP, ATP), 0.18 mM rGTP, 30 mM DTT, 40U RNasin 
and 0.36 mM 5' 7meGppp 5'G for one hour at 37°C. Uncapped mRNA was 
transcribed in the absence of 5'-7meGppp 5'G. After one hour, an additional 30 U 
of T3 RNA polymerase was added and the reaction was incubated at 37°C for an 
additional 30 minutes. pAl-230 was transcribed with T7 RNA polymerase and the 
DNA template was removed by treatment of the reaction with 15 U of RNase free 
DNase and 2 mM CaCl for 30 minutes at 37°C. Following the DNase treatment, the 
reaction volume was brought to 100 µl by addition of RNase free dH20 and 
phenol/chloroform extracted two times. The synthesized capped RNA was then 
ethanol precipitated and resuspended in 5 µl RNase-free dH20. The RNA was 
translated with 15 µl of Ambion nuclease treated reticulocyte lysate in the presence 
of 50 µCi [35S] Methionine. To determine the time course of the translation 
reaction, 5 µl aliquots were removed from the reactions at 15, 30, and 60 minutes. 
The translation products were analyzed by electrophoresis through 10% SDS 
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polyacramide gels followed by western blotting and autoradiography. For western 
blots, the SOS-PAGE seperated proteins were transfered to a nitrocellulose paper 
with a Poly blot at 2.5 m.A/cm2 for 40 min. After the transfer, the nitrocellulose 
paper was incubated in a blocking solution containing 10% calf serum in TBS for 
one hour and incubated overnight with a 100 fold dilution of the eIF-2B antibody. 
Following this incubation, detection of immunoreactive polypeptides were essentially 
the same as those used for immuno screening of the cONA library. 
Characterization of the mRNA Encoding eIF-2BE 
Poly (A+) RNA was isolated from rabbit reticulocytes by a slight modification of 
the method of Badley et. al. (63). 5 ml of a buffer containing 400 mM NaCl, 400 
mM Tris/HCl (pH 7.5), 3.0 mM MgC12, 4% SOS and 400 µg Proteinase K was 
added to 5 ml of rabbit reticulocyte lysate, followed by incubation of the lysate at 
45 ° C for two hours with intermittent agitation. The lysate was then added directly to 
oligo ( dT) cellulose previously equilibrated with a buffer containing 10 mM 
Tris/HCl (pH 7.5) and 500 mM NaCl. The poly (A+) RNA was bound by 
incubating the mixture at room temperature with agitation for 20 minutes. The oligo 
( dT) cellulose was washed with the binding buffer until no absorbance was detected 
at 260 nm. Poly (A+) RNA was then eluted from the oligo (dT) cellulose with 10 
mM Tris/HCl (pH 7.5), 1 mM EOTA and 0.1% SOS (elution buffer). The RNA 
was precipitated by the addition of 2.5 volume 95% ethanol. The precipitated 
mRNA was resuspended in 20 µl of the elution buffer. 
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The isolated poly (A+) RNA preparations were treated with glyoxal at 65 ° C for 
one hour and fractionated on a 1 % agarose gel. After electropherorsis, the 
fractionated RNA was transferred to a nylon membrane by capillary transfer for 24 
hours and hybridized to radiolabeled P1068 under conditions identical to those 
described for hybridization of biotinylated P1068. Following hybridization, the 
membrane was washed four times for 15 minutes each at 55°C with 2xSSC, 1% 
SDS; two times with lxSSC, 1% SDS at 55°C for 15 minutes each; two times with 
0.5x SSC, 1 % SSC at 55 °C for 15 minutes each; and a final wash with 0.5x SSC at 
room temperature. The membrane was then dried and exposed to Kodak XAR-5 
film at 70 ° C for one week. 
Deletion Analysis of the 5' end of pAl cDNA 
To help determine the initiating codon for the isolated cDNA, three deletions 
were made into pAl with unique restriction at the 5' terminal of pAl to generate the 
following plasmids; pAl-172, pAl-230 and pAl-369 (figure 2). pAl-172 was 
prepared by digesting 5 µg of cesium chloride gradient purified pAl with 10 U of 
BamHI at 37°C for 90 minutes, followed by purification by phenol/chloroform 
extraction and ethanol precipitation. 1 µg of the BamHI linearized pAl was then 
digested with 2 U of Ppuml. The ends of the resulting DNA were filled in by the 
addition of 1 U of Klenow and 0.2 mM NTP with a further incubation at 37 ° C for 
30 minutes. Intramolecular recircularization of the DNA was carried out by the 
addition of 1 U of T 7 ligase in a reaction mixture containing 10 mM 
Figure 2. 5' Deletion Analysis of pAI cDNA. 
a; Partial Restriction Map of pA I showing unique restriction enzyme sites and their 
relative positions on pAI. These sites include the restriction enzymes used for 
the deletion analysis. 
b; Deletion with Barn.HI on pBS and pPuml on pAI removes 183 nucleotides from 
the 5' terminus of pAI to generate the plasmid pAI-172. The plasmid pAI-230 
was generated by digestion of pAI with EcoRI, which removes 230 nucleotides 
from the 5' terminus of pAI. Restriction with Sacl removes 365 nucleotides 
from pAI generating the plasmid pAI-369. Because all deletions were made 
using unique restriction sites on pBS multiple cloning site and pAI, the T3 and 
T 7 promotor were not destroyed, allowing in vitro synthesis of mRNA using the 
respective polymerase. 
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hexaaminecobalt, 25 mM Tris/HCI (pH 7.5), 5 mM MgC12, 1 mM DTT and 400 mM 
KCl in a total reaction volume of 50 µl for one hour at room temperature. 10 µl of 
the recircularization reaction mixture was used to transform component XL-1-Blue 
cells as described by Hannaha (63). Transformed cells were plated on a LB agar 
plate supplemented with X-gal and 50 µg ampicilin (amp) and grown overnight at 
· 3 7 ° C. Clear colonys from this plate were restreaked on amp supplemented LB plates 
and incubated overnight at 3 7 ° C. pA 1-172 was isolated from bacteria culture grown 
from a single colony on this plate using the alkaline denaturation method described 
in USB sequencing support manual. 
For pAl-369, 1 µg of pAl was digested with 2 U of Sacl and purified by 
phenol/chloroform extraction and ethanol precipitation. After purification, the 
experimental procedures used to generate pAl-369 were essentially the same as 
those used for pAl-172 except that end filling with Kienow was not performed. 
Restriction of pAl with EcoRl frees it from the vector. So to obtain pAl-230, 
10 µg of EcoRl digested pAl was electrophoresed on a 1.2% low melting point 
agarose. The band corresponding to the 2328 bp fragment was then extracted from 
the agarose gel using USBioclean kit. The extracted DNA was then subcloned into 
pBluescript generating pAl-230. The plasmid isolation was the same as that 
described for pAl-172. 
To verify the extent of the deletions, each of the constructed plasmids was 
restricted with Pvul and the reaction mixture electrophoresed on a 1.2% agarose gel 
(figure 3). 
Figure 3. Restriction Analysis of pAl, pAl-172, pAl-230, and pAl-369. 
0.3 µg of each of the plasmid were digested with 1 U of Pvul and electrophoresed 
through a 1.2% agorose gel. Lanes: 1, 1 kb ladder DNA; 2, pAl; 3, pAl-172; 4, 
pAl-230; 5, pAl-369. 
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Glycerol Gradient of In Vitro Translated eIF-2BE 
5 µl of the translated product for pAl was diluted with one half volume of a 
buffer containing 20 mM Tris/HCl (pH 7.5), 1 mM DDT and 0.2 mM EDTA and 
separated on a linear 15% to 50% glycerol gradient by centrifugation at 45,000xg for 
18 hours. 200 µl fractions were collected. Fractionated proteins were precipated 
with 300 mM NaOAc, 5 µg BSA and 2 volume of 95% ethanol at -20°C overnight. 
Precipitated protein were collected by centrifugation at 12,000g for 15 minutes and 
redissolved in 50 µl of Laemmilli buffer (65). The resuspended proteins were 
denatured by boiling for one minute and electrophoresed through a 10% SDS 
polyacrylamide gel. After electrophoresis, the proteins were transfered to a PVF 
membrane as described previously. Proteins were visualized by autoradiography 
with Kodak XAR-5 film at room temperature. 
CHAPTER IV 
RESULTS 
Isolation and Analysis of the Nucleotide Sequence of the cDNA 
Encoding eIF-2BE 
The cDNA encoding e1F-2B8 was isolated by antibody screening of a rabbit 
reticulocyte lysate library in A-ZAP (Stratagene). Of the 337,500 recombinants 
screened, only a single immunopositive clone was isolated. To determine the 
approximate size and confirm the immunoreactivity of the encoded protein, the 
isolated clone was subsequently subcloned into pBluescript by in vivo excision and 
expressed in E.coli. In E.coli, the recombinant protein is expressed as a fusion 
protein with 34 amino acids of J3-galactosidase under the control of the lac repressor 
(66). Upon induction with IPTG, a new protein with a molecular weight of 
approximately 88 kDa was observed to be present in cell extracts analyzed on a 10% 
SDS polyacryamide gel (figure 4). Western blot of the gel with antibody directed 
against eIF-2B showed two bands, one corresponding to the induced fusion protein 
(figure 4) and the other comigrating with the 82 kDa subunit of purified 
nonrecombinant eIF-2B (figure 5). The expressed protein did not react with 
preimmune antiserum indicating that it is specific to the eIF-2B antibody. 
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Figure 4. Expression ofpAl in E.coli. 
Following induction of the synthesis of fusion protein with IPTG, the E.coli cells 
were lysed and 30 µl of the soluble protein supernatant NAS electrophoresed 
through a 10% SDS polyacryamide gel. The proteins were then visualized by 
Coomassie blue staining. Lanes: 1, IPTG induces expression from pBS; 2, IPTG 
induced expression of pAl (-- shows the new protein); 3, uninduced expression of 
pAl; 4, purified eIF-2B (* shows eIF-2Bic;); 5, molecular weight standard. 
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Figure 5. Western Blot Analysis of the Protein Expressed from pAl in E.coli. 
Protein samples from E.coli expressing pAl were electrophoresed through a 10% 
SDS polyacramide gel, transfered to nitrocellulose membrane and probed with a 
1 : 100 dilution of a polyclonal antibody directed against all subunits of eIF-2B. 
Lanes: 1, purified eIF-2B; 2, protein sample from the IPTG induction of pBS 
expression in E.coli; 3, proteins from the IPTG induced expression of pAl in 
E.coli. 
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After digestion of pAl with EcoRI, DNA fragments were separated by 
electrophoresis through agarose gels. Three bands with sizes of approximately 2900, 
2200, and 230 bp (figure 6, lane 2) were observed upon staining the gels with 
ethidium bromide. Since the upper 2900 bp band corresponds to the vector 
sequence, the cDNA insert contains one internal EcoRI site and is approximately 
2500 bp in size. The average molecular weight of an amino acid is 110 Da, 
therefore, approximately 2240 bases of coding sequence is required to produce a 
polypeptide of 82 kDa protein. Therefore, the 2500 bp insert of pAl cDNA 
contains sufficient DNA sequence to encode the 82 kDa subunit of eIF-2B. 
Nucleotide sequencing of cDNA revealed the size of the pAl cDNA is 2516 
nucleotides, consistent with the size of the cDNA estimated by agarose gel 
electrophoresis. Analysis of the pAl cDNA sequence using Macvector sequence 
analysis program revealed an opening reading frame extending from the second 
nucleotide to nucleotide 2152. The open reading frame is followed by 408 
nucleotides of untranslated 3' sequence that lacks a consensus polyadenlylation 
signal and a poly-A tail. The first 120 nucleotides of the pAl cDNA is extremely 
GC rich with a G+C content between 70% - 90% (figure 7a & 7b). The pAl cDNA 
sequence lacks an initiating AUG codon immediately downstream from the 5' 
terminus. The first AUG codon is found at nucleotide 550 which would code for a 
protein with a predicted molecular weight of 65 kDa. Therefore, one possibility is 
that the cDNA is not full length. Another possibility is that the cDNA does encode 
Figure 6. EcoRI Restriction Analysis of pAl, pA2, and pA3. 
0.3 µ,g of the respective plasmids wre digested with 1 U of EcoRI and· 
electrophoresed through a 1.2% agarose gel. The bands were then visualized by 
ethidium bromide staining. Lanes: 1, 1 kb DNA ladder; 2, pAl; 3, pA2; 4, pA3. 
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Figure 7. Percent G+C Content of the cDNA for eIF-2BE. 
a. The percent of G+C content of the entire nucleotide sequence of the cDNA 
encoding eIF-2BE was analyzed using the percent G+C analysis program on 
Macvector. 
b. Percent G+C content of only the first 200 nucleotide of the cDNA for eIF-2BE. 
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full-length, but the observed band at 82 kDa is due to anomolus migration on SDS 
gels or due to post-trranslational modification of the proteins. 
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In order to distinguish between these alternatives, an attempt was made to isolate 
a longer cDNA by rescreening the reticulocyte lysate library with P1068, a 
nucleotide probe generated from the sequences of the immunopositive clone. Of the 
150,00 recombinant phages screened, two additional positive clones were isolated. 
Plasmid DNAs were recovered by in vivo excision and the cDNA inserts were 
analyzed by EcoRl digestion followed by electrophoresis through a 1 % agarose gel. 
Both plasmids (pA2 and pA3) were found to have fragments of similar size to those 
generated from pAl (figure 6). Terminal DNA sequence analysis with T3 primer 
showed that all three have identical terminal sequences. Therefore, pAl, pA2, and 
pA3 are identical clones. 
Analysis of the Deduced Amino Acid Sequences of eIF-2BE 
The nucleotide sequence and the deduced amino acid sequence of pAl cDNA 
are shown in figure 8. The longest open reading frame begins at nucleotide 2, 
however, the GTG codon at nucleotide position 23 has been tentatively identified as 
the initiating codon (see next section for explanation). The predicted protein is 711 
amino acid residues in length and has an estimated molecular weight of 79,381 kDa, 
consistent with the observed mobility of eIF-2BE on 10% SDS-polyacrylamide gels. 
The amino acid composition of the derived sequence of the predicted protein is 
shown in table I. The percent composition of the amino acids in the protein is 
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consistent with those expected for vertebrate proteins except for a 50% elevation in 
the number of glutamate residues. This increase in glutamate residues gives the 
predicted protein an acidic pl of 4.9. Although, the percent composition of glycine 
falls within the the expected value, the predicted protein has an unusual cluster of 
glycine at its N-terminus. 
Microsequence analysis of SDS-P AGE purified eIF-2BE was performed, 
following partial hydrolysis with V8 protease (Shaun N. Thomas, unpublished 
results). The two peptide sequences H2N-N V LLGSFNVIGSN-CO 2 and H2N-
XXVIXLXXPXA-C02 were obtained. The predicted amino acid sequence of pAl 
cDNA contained the sequence H2N-NVLLGSGTVIGS N-C02 (underlined in figure 
8), this sequence differed at only two positions from that obtained from 
microsequencing of one of the V8 fragments. On the V8 fragment, residue 7 and 8 
are phenylalamine and alanine instead of glycine and threonine observed in the 
predicted amino acid sequence. The amino acid sequence H2N-GSVISLHPPEA-CO 2 
was also present in the predicted amino acid of pAl cDNA. Although, the 
underlined amino acid residues in the predicted sequence (H2N-GSVIS..LHPPE_A-
C02) were not conclusively determined by microsequencing, this sequence like the 
previous sequence is preceded by an acidic residue in the pAl sequence; acidic 
residues mark the cut site for V8 protease. Moreover, the spacing between the 
identified and the unidentified residues in the V8 fragment sequence are an exact 
match to the predicted sequence. The presence of these peptide sequences in the 
Figure 8. Nucleotide and Deduced Amino Acid Sequences of eIF-2BE. 
The deduced amino acid sequence of eIF-2BE is given below the nucleotide 
sequence. Translation is postulated to begin from the GTG codon begining at nt 
23. The open reading frame then extends from this codon to the termination 
codon TGA beginning at nt 2158. This corresponds to a protein of 711 amino 
acids to give a protein with a calculated molecular weight of 79 kDa. The 
underlined amino acids represent those corresponding to the sequence obtained 
from the peptide sequencing of V8 fragments of eIF-2BE. The ATG codons 
beginning at nt 530 or 536 and 854 represent possible translation of initiation 
codons for the 65 and 58 kDa proteins observed on SOS polyacrylamide 
electrophoresis gel of the translation product of this cDNA. -- indicates possible 
phosphorylation site for casein kinase II. 
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10 20 30 40 50 
GCCGC ccccc CCGCC TGGTC CA CTG TCT GAT CGG CCC MC MG CCC GGC GCG GGC 
Val Ser Asp Arg Ala Asn Lys Arg Cly Cly Cly> 
60 70 80 90 100 
CCA GGA CCC GGT GGC GGC CCC GGG GGA CCC CGA GGT GCG GAG GAG GAG TCT CCC 
Pro Cly Cly Cly Cly Cly Cly Cly Cly Ala Arg Cly Ala Glu Glu Glu Ser Pro> 
110 120 130 140 150 160 
. 
CCC CCC CTC CAG CCC CTC CTG GTG CCC CAT ACC 'ITC MC CCC CGT TTC TTC CCC 
Pro Pro Leu Gln Ala Val Leu Val Ala Asp Ser Phe Asn Arg Arg Phe Phe Pro> 
170 180 190 200 21C 
ATC TCC AAG GAC CAG CCT CGG GTC CTC CTG CCT CTG CCC MT GTC CCC CTA AT!' 
Ile Ser Lys Asp Gln Pro Arg Val Leu Leu Pro Leu Ala Asn Val Ala Leu Ile> 
220 230 240 250 260 270 
GAC TAC ACT CTG CAA TTC CTG ACT CCC ACA GGT GTA CAG GAG ACC T1'1' GTG TTT 
Asp Tyr Thr Leu Glu Phe Leu Thr Ala Thr Cly Val Gln Glu Thr Phe Val Phe> 
280 290 300 310 . 320 
. 
TGT TGC TGG MC CCT GCT CAG ATC AAA GM CAT 'ITC CAA AAA TCC MG TGG TGC 
Cys Cys Trp Lys Ala Ala Gln Ile Lys Glu His Leu Gln Lys Ser Lys Trp Cys> 
330 340 3SO 360 370 
CCC CCA ACA TCC CTC MC GTG GT'!' CGG,ATA A'M' ACA TCA GAG CTC TAC CCA TCG 
Arg Pro Thr Ser Leu Asn Val Val Arg Ile Ile Thr Ser Glu Leu Tyr Arg Ser> 
380 390 400 410 420 430 
CTG GGA CAT GTC CTC CGT CAT GTT GAC CCC AAA CCC CTG GTG CCC TCT GAC 'ITC 
Leu Cly Asp Val Leu Arg Asp Val Asp Ala Lys Ala Leu Val Arg Ser Asp Phe> 
440 450 460 470 480 
. 
CTC CTG GTG TAC GGA CAT GTC GTC TCC MC ATC MT GTC ACC AGG CCC CTC GAG 
Leu Leu Val Tyr Gly Asp Val Val Ser Asn Ile Asn Val Thr Arg Ala Leu Glu> 
490 500 510 520 530 540 
. 
GM CAT AGC TTA AGG CGG AAG CTA GM AAA MT GTG TCT GTG ATG ACA ATG ATC 
Glu His Arg Leu Arg Arg Lys Leu Glu Lys Asn Val Ser Val Met Thr Met Ile> 
550 560 570 580 590 
TTC AAA GM TCA TI:C CCC AGC CAC CCC ACT CGT TGC CAT GAG GAC MT GTG GTA 
Phe Lys Glu Ser Ser Pro Ser lli s Pro Thr Arg Cys His Glu Asp Asn Val Val> 
600 610 620 630 640 
GTG GCT GTG CAT AGT CCC ACA AAC CGG ATT CTC CAC TTC CAG AAG ACC CAG GGC 
Val Ala Val Asp Ser Ala Thr Asn Arg Ile Leu His Phe Gln Lys Thr Gln c:,-,-
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650 660 670 680 690 700 
• * • 
. . 
CTC CGA CGT TTC TCT TTT CCT CTG AGC CTG TTC CAA GGC AGT GGC GCT GGC GTG 
Leu Arg Arg Phe Ser Phe Pro Leu Ser Leu Phe Gln Gly Ser Gly Ala Gly Val> 
710 720 730 740 750 
. 
* * * 
GAG ATT CGG TAT GAC TTA TTG GAT TGT CAT ATC AGC ATC TGC TCC CCT CAG GTG 
Glu Ile Arg Tyr Asp Leu Leu Asp Cys His Ile Ser Ile Cys Ser Pro Gln Val> 
760 770 780 790 BOO 810 
• * • • * 
. 
GCT CAG CTC TTC ACA GAC AAC TTT GAC TAC CAG ACT.CGA GAT GAC TTT GTG CGA 
Ala Gln Leu Phe Thr Asp Asn Phe Asp Tyr Gln Thr Arg Asp Asp Phe Val Arg> 
820 830 840 850 860 
* * * 
GGC CTG TTA GTG AAC GAG GAG ATC CTA GGG AAC CAG ATC CAC ATG CAT GTA ACA 
Gly Leu Leu Val Asn Glu Glu Ile Leu Gly Asn Gln Ile His Met His Val Th~> 
870 880 890 900 91 
* * 
.-
ACT AGG GAA TAC GGT GCC CGG GTC TCC AAC CTG CAC ATG TAC TCT GCT GTC TGT 
Thr Arg Glu Tyr Gly Ala Arg Val Ser Asn Leu His Met Tyr Ser Ala Val Cys> 
920 930 940 950 960 970 
. . 
* 
. 
GCC GAT GTC ATC CGC CGA TGG GTC TAC CCT CTC ACC CCA GAG GCA AAC TTC ACT 
Ala Asp Val Ile Arg Arg Trp Val Tyr Pro Leu Thr Pro Glu Ala Asn Phe Thr> 
980 990 1000 1010 1020 
• * • 
. 
* 
GAC AGC ACC GCT CAG AGC TGC ACT CAT TCC CGG CAC AAC ATC TAC CGA GGG CCC 
Asp Ser Thr Ala Gln Ser Cys Thr His Ser Arg His Asn Ile Tyr Arg Gly Pro> 
1030 1040 1050 1060 1070 1090 
*· * 
. 
* * 
. 
GAG GTC AGC TTG GGC CAT GGC AGC ATC CTG GAG GAG AAT GTA CTC CTG GGC TCT 
Glu Val Ser Leu Gly His Gly .S.e~ Ile Leu Glu Glu Ase Val Ley Ley Gly Ser>· 
1090 1100 1110 1120 1130 
* * 
. . 
GGC ACT GTC ATT GGC AGC AAC TGC TCT ATC ACC AAC AGT GTC ATT GGT CCT GGC 
Gly Thr Val Ile Gly Ser Asn Cys Ser Ile Thr Asn Ser Val Ile Gly Pro Gly> 
1140 1150 1160 1170 1180 
* * 
. 
* 
TGC TGC ATT GGT GAT AAC GTG GTG CTG GAC CGG GCC TAC CTG TGG AAA GGT GTT 
Cys Cys Ile Gly Asp Asn Val Val Leu Asp Arg Ala Tyr Leu Trp Lys Gly Val> 
1190 1200. 1210 1220 1230 1240 
. • . • * 
CAA GTG GCT TCT GGG GCG CAG ATC CAT CAG TCT CTG CTC TGT GAC CAT GCT GAG 
Gln Val Ala Ser Gly Ala Gln Ile His Gln Ser Leu Leu Cys Asp His Ala Glu> 
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1250 1260 1270 1280 12-90 
• . . 
GTC MG GM CAA GTG ACA CTG MG CCA CAC TGT GTC CTT ACT TCC CAG. GTG GTA 
·val Lys Glu Gln Val Thr Leu Lys Pro His Cys Val L·eu Thr Ser Gln Val Val> 
1300 1310 1320 1330 1340 1350 
• • * • * 
. 
GTG GGC CCC MC ATC ACG CTG CCT GAG GGC TCG GTC ATC TCT TTG CAC CCT CCA 
Val Gly Pro Asn Ile Thr Leu Pro Glu Gly Ser Val Ile ser Leu His Pro Pro> 
1360 1370 1380 1390 1400 
* 
. . . 
GAT GCA GM GM GAT GAG GAT GAT GGC CAG TTC AGT GAT GAT TCT GGG GTC AAC 
Asp Ala Glu Glu Asp Glu Asp Asp Gly Gln Phe Ser Asp Asp Ser Gly Val Asn> 
1410 1420 1430 1440 1450 
. . 
* 
. 
CAA GCA AAG GAG AAA GCG AAG CTG AAA GGT TAC MT CCA GCG GAA GTA GGA. GTT 
Gln Ala Lys Glu Lys Ala Lys Leu Lys Gly Tyr Asn Pro Ala Glu Val Gly Val> 
1460 1470 1480 1490 1500 1510 
* 
. . 
GCA GGC AAA GGC TAC CTC TGG AAA GCT GCT GAC ATG AAC ACG GAG AAA GAG GAA 
Ala Gly Lys Gly Tyr Leu Trp Lys Ala Ala Asp Met Asn .Ih.t: Glu Lys Glu Glu> 
1520 1530 1540 1550 1560 
* * • 
. 
GAA CTG CGG CAG AGT CTG TGG GGA CTC ACA ATC AAT GAG GAA GAG GAG AGT GAG 
Glu Leu Arg Gin Ser Leu Trp Gly Leu .I.hL Ile Asn Glu Glu Glu Glu ,Se,t: Glu> 
1570 1580 1590 1600 1610 1620 
• . * * 
ACT GM AGT GAG CGA AGC ATG GAT TCT GAG GAG CTG GAC AGC CGA GCA GGC TCC 
Thr Glu Ser Glu A;:g Ser Met Asp Ser Glu Glu Leu Asp Ser Arg Ala Gly Ser> 
1630 1640 1650 1660 1670 
* 
. 
CCC CAG TTG GAT GAC ATC AAA GTG TTC CAG MT GAA GTC CTG GGA ACA CTG CAG 
Pro Gln Leu Asp Asp Ile Lys Val Phe Gln Asn Glu Val Leu Gly Thr Leu Gln> 
1680 1690 1700 1710 1720 
* * 
. • 
CGG GGC AAA GAA GAG AGC ATT TCT TGT GAC MT CTC ATC CTG GAG ATC MC TCT 
Arg Gly Lys Glu Glu Ser Ile Ser Cys Asp Asn Leu Ile Leu Glu Ile Asn Ser> 
1730 1740 1750 1760 1770 1780 
• * * 
. 
* * 
CTC MG TAT GCC TAC AAC ATA AGC CTA MG GAG GTG ATG CAG GTA CTG AGC CAT 
Leu Lys Tyr Ala Tyr Asn Ile Ser Leu Lys Glu Val Met Gln Val Leu Ser His> 
1790 1800 1810 1820 1830 
. . . . 
GTG GTC CTG GAG TTC CCA CTG CAA CAA ATG GAT TCC CCG CTG GAG GCA AAC CGC 
Val Val Leu Glu Phe Pro Leu Gln Gln Met Asp Ser Pro Leu Glu Ala Asn Arg> 
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1840 1850 1860 1870 1880 1890 
. • * * 
TAC TGT GCC CTG CTG CTT CCT TTG CTC AAG GCC TGG AGC CCT GTT TTT AGG AAC 
Tyr Cys Ala Leu Leu Leu Pro Leu Leu Lys Ala Tr-p Ser Pr-a Val Phe Ar-g Asn> 
1900 1910 1920 1930 1940 
* * * 
TAC ATA MG CGT GCA GCC GAC CAT TTG GAA GCA TTG GCA GCC ATT GAG GAG. TTC 
Tyr I le Lys Arg Ala Ala Asp His Leu Glu Ala Leu Ala Ala Ile Glu Glu Phe> 
1950 1960 1970 1980 1990 
* * * * 
TTC CTG GAG CAT GAA GCT CTT GGT ACT TGC ATA GCC AAG. GTA CTG ATG GGT TTC 
Phe Leu Glu His Glu Ala Leu Gly Thr Cys Ile Ala Lys Val Leu Met Gly Phe> 
2000 2010 2020 2030 :040 20SO 
* * * * * 
TAC CAG CTA GAG ATC CTG GCT GAG GAG ACG ATC. CTG AGC TGG TTC GGC CAA' AGG 
Ty·r Gln Leu Glu Ile Leu Ala Glu Glu Thr Ile Leu Ser Trp Phe Gly Gln Arg> 
2060 2070 2080 2090 2100 
* * * * 
GAT GTA ACG GAC AAG GGC CGG CAG CTG CGC AAG AAC CAG CAG CTA CAG AGG TTC 
Asp Val Thr Asp Lys Gly Arg Gln Leu Arg Lys Asn Gln Gln Leu Gln Arg Phe> 
2110 2120 2130 2140 2150 2160 
* * * 
ATC CAG TGG CTA AAA GAG GCA GAA GAG GAG TCA TCT G.V. GAT GAC TGA AGTCA 
Ile Gln Trp Leu Lys Glu Ala Glu Glu Glu Ser Ser- Glu Asp Asp ***> 
2170 2180 2190 2.200 2210 2220 
* * 
. . 
CATGC TGCCC GCTCC TGGGG CTCTG AGTCA TTGTC CTCCT GGTTC CTGGG CCAGG ACAAG 
2230 2240 2250 2260 2270 2280 
* * * * * * 
TGCGG AGCTG GTTGT GGAAG GATGA GTGAC CACCG TCCCG TGACC CAAGG AGCAG AGGCT 
2290 2300 2310 2320 2330 2340 
* * 
GGAAC TACAG TATTC ACACT GCCAG CAACC ATGTG CCTCC CGTCC CAACT GGGGC ACTGG 
2350 2360 2370 2380 2390 2400 
* * * * 
. 
GATGA GGGAA GTCAG ACTGG AACAA AGCAT CTGCC TAGGG AGGAG CTGGG CAGGC CTGCG 
2410 2420 2430 2440 2450 2460 
. 
* * * 
GTTGG AGGAA GGCCA GAGGA ACCTG TGTGC TCGGG. CTCTC CCTC.A GGGAA CAGCA GAGAG 
2470 2480 2490 2500 2510 
* * 
. 
CAGCT GGCCT CTCTG CTGCT TGTAT TTGTT AATAT TAAAA AAGAG AGGCG GCCGC G 
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Table 1: Amino Acid Composition of the 82 kDa Subunit of eIF-2B 
Amino acid No.present Percent 
Ala 46 6.47 
Val 58 8.16 
Leu 76 10.69 
Ile 35 4.92 
Pro 27 3.80 
, Met 9 1.27 
Phe 25 3.52 
Trp 9 1.27 
Gly 49 6.89 
Ser 55 7.74 
Tor 32 4.50 
Cys 16 2.25 
Tyr 17 2.39 
Asn 31 4.36 
Gln 34 4.78 
Asp 40 5.63 
Glu 61 8.58 
Lys 31 4.36 
Arg 40 5.63 
His 19 2.67 
sequence of amino acids predicted in the open reading from pAl cDNA confirms 
that the isolated cDNA encodes eIF-2BE. 
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The native eIF-2BE subunit is believed to be a substrate for phosphorylation by 
casein kinase II, a serine/threonine kinase which phosphorylates the consenus 
sequence Ser/Thr XX Glu/Asp. The deduced amino acid sequence of eIF-2BE 
contains several putative phosphorylation sites, at positions Thr-281, Ser 343, Thr 
493, Thr 507, Ser 514, and Ser 706. The sequence Ser-514 Glu Thr Glu is the same 
as the consensus sequence phosphorylated by casein kinase II in fibrogen (65). 
A hydrophilicity plot generated for the derived eIF-2BE sequence predicts that 
eIF-2BE is a hydrophilic protein (figure 9a). The antigenic index and surface 
probability of the deduced sequence were also obtained to identify peptides of eIF-
2BE that would have a high probability of generating an immune response in a host 
(figure 9b). The overall antigenicity index of eIF-2BE is low, however, synthetic 
peptides corresponding to the residues spanning amino acids 250 to 258 and 690 to 
700 could be useful for antibody production, since their surface probabilities are 
high. The secondary structure profile of the derived sequence indicated that eIF-2BE 
has a complex secondary structure with no predominant secondary structure pattern 
(figure 9d). 
Figure 9. Structural Analysis of the Amino Acid Sequence of eIF-2BE. 
a. Hydrophility plot of eIF-2BE was performed with a window of 8. 
b. Surface probability of eIF-2BE. 
c. Antigenic index of eIF-2BE. 
d. Secondary structure analysis of eIF-2BE. 
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In Vitro Transcription and Translation of eIF-2BE cDNA 
Since pAI cDNA (eIF-2BE cDNA) is expressed as fusion protein that contains 
34 amino acids of p-galacosidase in E.coli, it is more difficult to deduce the 
molecular weight of the protein encoded by the cDNA. To verify that the eIF-2BE 
cDNA encodes full length eIF-2BE and to determine the apparent molecular weight 
of the encoded protein without interference from the 34 amino acids of P-
galacosidase, eIF-2BE cDNA was transcribed in vitro. The capped mRNA was 
translated in nuclease treated reticulocyte lysate in the presence of [35S] methionine 
and the translation products were separated by SDS/P AGE and transfered to PVDF 
membranes. The autoradiograph of the Western blot revealed multiple protein bands 
(figure 10). Three of the protein bands comigrated with the 82, 65, and 58 kDa 
subunits of endogenous eIF-2B detected by western blotting using the chicken anti-
eIF-2B antiserum. A fourth protein of approximate molecular weight of 72 kDa was 
also observed. A time course of the translation of the transcribed mRNA indicates 
that the 72 kDa, 65 and 58 kDa products are not produced by proteolytic digestion 
of the 82 kDa protein (figure 11). The 82 kDa protein is the largest protein 
translated and its presence indicates that the isolated cDNA encodes full length eIF-
2B. Therefore, the most likely explanation is that the 65 and 58 kDa proteins are 
due to initiation at internal AUG codons located at nucleotide 550 and 854 
respectively. The 72 kDa protein is also most likely the result of internal initiation 
Figure 10. In Vitro Transcription and Translation of eIF-2BE cDNA. 
3 µg of EcoRV linearized pAl was transcribed and the resulting mRNA translated 
in nuclease treated reticulocyte lysate. Autoradiography of western blot of the 
translation products separated by SDS-PAGE, gave multiple protein bands, three of 
which correspond to eIF-2B subunits. Lanes: 1, western blot of endogenous eIF-
2B; 2, autoradiography of the translation product of eIF-2BE cDNA. 
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Figure 11. Time Course of elF-2Bs cDNA In Vitro Translation. 
3 µg of EcoRV linearized pAl was transcribed in the presence and absence of the 
cap analog. The resulting capped and uncapped mRNA were translated in nuclease 
treated reticulocyte lysate. Aliquots were removed from the translation reactions 
containing uncapped mRNA (lanes 1-3), capped mRNA (lanes 4-6), or no mRNA 
(lanes 7-9) at 15, 30, and 60 minutes, and analyzed. Lanes: 1, 4, and 7, aliquots 
taken at 15 minutes; lanes 2, 5, and 8, aliquots taken at 30 min; lanes 3, 6, and 9, 
aliquots taken at 60 minutes. 
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from non AUG codon upstream of these AUG codons. The predominance of the 72 
kDa, 65 kDa, and 58 kDa proteins in translation products of uncapped mRNA 
transcribed from eIF-2B8 cDNA appear to support the explanation that they are 
produced due to internal initiation. The presence of the 65 and 5 8 kDa bands also 
suggests that the longer 82 kDa translation product is generated from a non AUG 
initiation codon located upstream of the AUG codons at nucleotides 550 and 854. 
To determine the location of the putative non AUG start codon, three deletions 
5' to the first AUG codon were generated by digesting with pPumI and BamHI 
(pAl-172), EcoRl (pAl-230) and Sacl (pAl-369). The truncated mRNA generated 
from pAl-172 lacked the codons GTG at nucleotide 23, CTG at nucleotide 128, and 
GTG at nucleotide 131, which are the likely non AUG codon used for initiation in 
eukaryotic cells (69). pAl-230 and pAl-369 also lacked the potential initiation 
codon GTG located at nucleotide 206 and 344, respectively. The truncated mRNAs 
generated from these deletions were translated in nuclease-treated reticulocyte lysates 
and the translation products were separated on a SDS/P AGE gel. Analysis of the 
translation products of each deletion indicated that all three deletions abolish the 
expression of the 82 kDa protein (figure 12 lane 3). In all cases however, the 72 
kDa, 65 kDa and 5 8 kDa protein continued to be expressed. This suggests that the 
72 kDa protein translation is initiated from a non AUG codon after nucleotide 369. 
Furthermore, since the expression of 82 kDa protein is abolished in the pAl-172 
construct, this suggests that its initiating codon is within the first 172 nucleotide of 
the cDNAs. The most likely codons to be used within this region includes the GTG 
Figure 12. In Vitro Translation of mRNA Transcribed from pAl-172, pAl-230, and 
pAl-369. 
Truncated mRNA transcribed from pAl-172, pAl-230, and pAl-369 were 
translated in nuclease treated reticulocyte lysate in the presence of [35S] 
methionine. The translation products were electrophoresized through a 10% SDS-
polyacrylamide gel and transferred to a PVDF membrane. Protein bands were 
visualized by autoradiography. Lanes: 1, negative control (-RNA); 2, pAl 
translation; 3, pAl-172 translation; 4, pAl-230 translation; 5, pAl-365 translation. 
The high molecular weight band on lanes 1 and 3 are absent in lanes 2, 4, and 5 
because of difference in exposure time. 
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codon beginning at nucleotide 23, CTG beginning at nucleotide 128 and GTG 
beginning at nucleotide 131. 
Similarity Between the Amino Acid Sequence of eIF-2BE and Yeast GCD6 
61 
The deduced amino acid sequence of eIF-2BE was compared with protein 
sequences in NBRF protein databank. The predicted amino acid sequence of eIF-
2BE showed a low homology with yeast GDCl and an unidentified open reading 
frame in E. coli. The homology with yeast GCDl (homology score 149) may be 
significant since this protein is postulated to be a subunit of eIF-2B in yeast. 
However, when the sequence of eIF-2BE was compared with yeast GCD6 (provided 
by J. Bushman & A. Hinnebusch, NIH), eIF-2BE was found to be 30% identical to 
GCD6 (figure 13) with the quality score for eIF-2BE aligned with GCD6 being over 
34 standard deviations greater than the mean score of randomized sequences. 
Comparison of eIF-2BE and GCD6 sequences revealed four regions with significant 
homology (figure 14). The highest degree of similarity was found in N-terminal 
regions which span amino acid 9 through 177 in eIF-2BE and 4 to 172 in GCD6. 
(figures 10, 15). Within this region, 55% of the amino acids are either identical or 
conservative substitutions. Strong similarity was also observed in region 2 which 
includes residues 221 to 283 of eIF-2BE and residues 220 to 283 of GCD6 (Figures 
14, 15) where 51 % of the amino acids are either identical or are conservative 
substitutions. A threonine residue at position 281 is conserved in both eIF-2BE and 
GCD6 and forms part of a concensus casein kinase II phosphorylation site. 
Figure 13. Alignment of the Amino Acids of eIF-2BE and GCD6. 
The alignment of eIF-2BE amino acid sequence with that of GCD6 was performed 
with best fit program. In this alignment, lines indicate identical amino acid 
substitutions, colons indicate conservative substitutions with similarity scores 
greater than 1.0 and periods represent similarity scores between 0.5 to 1.0. 
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Figure 14. Dot-matrix Comparison of eIF-2BE and GCDl. 
Dot-matrix comparison analysis of the two proteins were performed with a window 
of 60 and stingency of 15. Four regions of sequence similarity between the two 
protein were apparent. Regions 1, 2, and 3 had over 50% amino acid similarity 
between the two proteins, while region 4 showed a low percentage similarity of 
21 %. The strongest sequence similarity was observed at the N-terminal of the two 
proteins. 
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Cysteine-237 is also conserved on both sequences in this region. The third region of 
sequence similarity extends from amino acid 322 to 428 of eIF-2BE and 316 to 423 
of GCD6 (figure 14 and 15). 46% of the amino acids within the region are either 
identical or are conservative substitutions. A fourth region of identity was found 
between residues 639 to 669 of eIF-2BE and 681 to 715 of yeast GCD6. However, 
this region is only 21 % similar (figure 14, 15). 
In addition to the strong sequence similarity in Region 2 and 3, both protein 
sequences have three cysteine residues that are conserved. In region 2, cysteine-232 
is conserved at the same position on both proteins. The other conserved cysteines 
are present in region 3 at positions 372 and 418 in eIF-2BE, and at positions 367 and 
413 in yeast GCD6. The second amino acid following these conserved cysteines is 
either a leucine or isoleucine in all. cases. Similar internal repeats containing 
cysteines have also been observed in yeast GCDI, suggesting that they may play a 
significant role in the secondary structure of these proteins. 
Glycerol Gradient Analysis of In Vitro Translated eIF-2BE 
To provide additional proof that the pAI cDNA encoded protein is the authentic 
eIF-2BE, the translation products of the cDNA were subjected to glycerol gradient 
centrifugation to determine if their sedimentation properties are identical to subunits 
of authentic eIF-2B. Following centrifugation, fractions were collected and 
subjected to SDS-PAGE and autoradiography. Three protein bands of approximately 
Figure 15. Amino Acid Sequence of the Regions with Similarity Between eIF-2BE 
and GCD6. 
Line 1 corresponds to GCD6 sequences and line 2 corresponds to elF-2BE 
sequences. 
Region 1 is comprised of amino acid residues 9 to 177 of eIF-2BE and 4 to 172 of 
GCD6; 
Region 2 includes amino acid residues 220 to 283 of eIF-2BE and residues 220 to 
283 of yeast GCD6; 
Region 3 shows similarity between amino acids 322 to 428 of eIF-2BE and 316 
to 423 of yeast GCD6; 
Region 4 is toward the C-terminal of both proteins and includes amino acids 639 
to 669 of elF-2BE and 681 to 715 of GCD6 . 
..J,. conserved cysteines and threonine. 
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82, 65, and 58 kDa of eIF-2B and a fourth of 72 kDa were observed in fractions 
with the same sedimentation properties as those expected for purified eIF-2/eIF-2B 
complex (figure 16). This result suggests that in vitro translated eIF-2Ba is 
incorporated into endogenous eIF-2/eIF-2B complex. In addition, the continued 
presence of the 65 and 58 kDa polypeptides indicate that they might be authentic 
eIF-2B subunits or that the N-terminal amino acids of eIF-2Ba are not required for 
the incorporation of eIF-2Ba into the eIF-2B complex. At present the peptide 
sequences of these subunits are unavailable for comparison. 
Characterization of eIF-2Ba mRNA 
In order to determine if the pAl (eIF-2Ba) cDNA is full length we performed 
Northern blot analysis of mRNA isolated from rabbit reticulocyte lysates. When 
reticulocyte lysate poly (A+) RNA was probed with radiolabeled P1068, a single 
mRNA of approximate 2.8 kb was observed (figure 17) which is very close in size 
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to the 2510 kb insert. The approximately 300 base pairs difference in length 
between the observed message and the cDNA can be accounted for in part by the 
absence of a poly (A+) tail on isolated cDNA. In addition, it is possible that the 5' 
terminus lacks some 5' non-coding sequence. However, the size of the eIF-2Ba 
mRNA is very close in size to the cDNA pAl insert and suggests that the pAl clone 
contains the complete coding region of eIF-2Ba gene. 
Figure 16. Glycerol Gradient Analysis of the Products of the In vitro Translation of 
eIF-2BE cDNA. 
In vitro translated pAl was fractionated on a 15% to 50% glycerol gradient and 
protein fractions collected. Proteins precipitated from these fractions were 
redissolved in sample buffer, electrophoresed on a 10% SDS gel and transferred to 
PVDF membrane. Autoradiography showed incorporation of in vitro translated 
eIF-2BE into endogenous eIF-2/eIF-2B complex. Lanes 15 and 16 shows the 
incorporation of eIF-2BE, the 67 and 58 kDa subunit of eIF-2B into this complex. 
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Figure 17. Northern Blot Analysis of eIF-2BE mRNA. 
10 µ,g of glyoxated poly (A+) RNA from rabbit reticulocyte lysate was 
electrophoresed on a 1.2% agarose gel. The fractionated RNA were transferred to 
a nylon membrane and probed with radiolabelled P1068. Lanes: 1, Biotinylated 
DNA standard; 2, Poly(A+) RNA from rabbit recticulocyte lysate. 
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CHAPTER V 
DISCUSSION 
We have isolated and characterized a 2516 bp cDNA encoding the 82 kDa 
subunit of rabbit reticulocyte lysate eIF-2B. The identification of eIF-2BE was based 
on the following criteria. First, expression of pAl cDNA in E.coli results in 
production of a 88 kDa fusion protein that specifically cross reacts with a chicken 
anti-eIF-2B antiserum. Second, the open reading frame of pAl cDNA contains two 
peptide sequences obtained from amino acid microsequencing of V8 fragments of 
SDS-PAGE purified eIF-2BE. Third, the deduced amino acid sequence has strong 
homology with yeast GCD6, a protein proposed to be the eIF-2BE analog in yeast 
(73). 
The isolated cDNA encodes full-length eIF-2BE. This conclusion is based on the 
following. (i) The open reading frame of isolated cDNA extends from nt 23 to nt 
2158 and encodes protein with a calculated molecular weight of 79 kDa. When the 
possible mobility change induced by phosphorylation of e1F-2BE is taken into 
account, the 79 kDa molecular weight is close to the 82 kDa observed for non 
recombinant eIF-2BE on SDS polyacryamide gels. (ii) Northern blot analysis of 
mRNA corresponding to eIF-2BE cDNA indicates that both are almost the same size. 
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(iii) Upon in vitro translation in nuclease treated reticulocyte lysate of mRNA 
transcribed in vitro from pAl cDNA, one of the translation products comigrated with 
the 82 kDa subunit of endogenous eIF-2B. (4) The 82 kDa polypeptide is no longer 
expressed from mRNA transcribed in vitro from cDNAs containing deletion from 
either the first 172 nt or nt 230 and 369 at the 5'end of e1F-2B cDNA. The inability 
to express eIF-2Bs from any of the three truncated mRNA shows that eIF-2Bs 
translation must be initiated from a non AUG codon since the first AUG codon is 
located at nucleotide 550. Further, the similarity between eIF-2Bs and GCD6 is 
highest at the N-terminal of both proteins which is part of the open reading frame 
that precedes the first AUG. The amino acid residues between 30 to 49 residues on 
eIF-2Bs has one of the highest similarity indicating that GTG and CTG beginning at 
nt 128 and nt 131 precedes the initiation codon. Therefore, the GTG codon at 
nucleotide position 23 is the most likely candidate for initiation. 
In most mammalian mRNAs studied to date, non AUG codons are used for 
initiation in conjunction with the AUG codon (69). eIF-2Bs is unique in this regard 
in that its translation from this cDNA appears to be initiated exclusively from a non 
AUG codon. However, the possibility exists that there might be an AUG codon in 
frame with the eIF-2Bs translational reading frame upstream of the proposed 
initiation codon that is not present in the pAl cDNA. 
The eIF-2Bs cDNA contains several characteristics that is associated with genes 
whose translation are initiated from non AUG codons. The 5' terminus is extremely 
GC rich with the region of highest GC content closely following the proposed 
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initiating codon. In genes that lack an AUG codon, GC-rich sequences have been 
proposed to facilitate formation of secondary structure which may slow down 
ribsome scanning and result in initiation at non AUG codons. However, translation 
initiation at non AUG codons is generally inefficient and we found that the 
expression of the 82 kDa product from the transcribed mRNA in nuclease treated 
lysate was generally less efficient than the expression of the lower molecular weight 
products that presumably initiate at internal AUGs. 
The high GC content of the 5' sequences in the eIF-2BE cDNA also suggests 
that the expression of eIF-2BE may be highly regulated as would be expected of a 
protein involved in translation initiation. Other mammalian mRNAs that have been 
found to contain GC rich 5' termini encode proteins that play key roles in cell 
growth (69). Because GC rich 5' termini modulate expression of proteins by 
forming secondary structures that impede translation, the lower translational 
efficiency results in low levels of these proteins, which is often the case for proteins 
whose expression is tightly regulated. Consistent with an essential role in cell 
growth for eIF-2B, deletion of any of the GCD genes in yeast results in cells that 
are non viable. 
The primary amino acid sequence of eIF-2BE showed some distinct features. 
One of these features is the cluster of 11 glycines at its N-terminus. Eight of these 
glycines are tandemly repeated. Glycine rich domains have been implicated in poly 
(A+) tail binding, raising the possibility that eIF-2BE may interact with the poly (A+) 
tail of mRNA. Van Heugten et. al. (60), have recently shown that eIF-2/eIF-2B 
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complex interacts with the cap structures of mRNAs. Secondary structure analysis 
of the deduced eIF-2Bs sequence also indicates that the glycine rich region is highly 
flexible. This flexibilty may be necessary for its role in eIF-2B activity/function. 
Of interest is the identification of nine of these glycines as possible myristoylation 
sites. Although they are all internal sequences, proteolytic processing may leave any 
of them as the N-terminal residue, which would be capable of being myristoylated. 
Thus, the N-terminal block observed for the eIF-2Bs subunit may possibly be 
myristate. 
Another feature of the eIF-2Bs sequence is the presence of six potential casein 
kinase II sites. The most notable site is located at ser-514, which contains identical 
sequence to the site phosphorylated by casein kinase in fibrogen. Other potential 
casein kinase II phosphorylation sites include Thr-493 and Thr-507, which both 
contain consensus sequences followed by two or more acidic residues. Similar 
clusters of acidic residues at the C-terminal side of casein kinase II phosphorylation 
sites have been shown to increase the likelyhood of phosphorylation (65). In 
addition, these residues are in a region with one of the highest surface probabilities, 
indicating that they should be accessible to kinase. Ser-706 is of particular interest 
because this potential casein kinase II phosphorylation sequence is conserved in both 
eIF-2BE and yeast GCD6. This observation suggests that this amino acid residue 
may be a phosphorylation site, if the regulation of eIF-2B activity through the 
phosphorylation of its 82 kDa subunit is conserved evolutionarily. Phosphopeptide 
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mapping, specific mutations and characterization of the mutants will be necessary to 
determine the exact residues phosphorylated. 
Comparison of the sequence of eIF-2Ba with yeast GCD6 revealed strong 
similarity between both proteins. The 30% overall identity between the proteins was 
the highest among any of the putative subunits of yeast eIF-2B suggesting that both 
proteins may share a common function in eIF-2B. The shared function may be 
mediated via their N-terminal since this region showed the strongest sequence 
similarity. Another region of interest includes the pocket of amino acids with 
conserved cystines followed by leucine or valine at the + 2 positions. Similar 
patterns are observed in GCDl and GCD7, which are both postulated to be subunits 
of yeast eIF-2B. Perhaps these cystines are required for folding/assembly of eIF-2B. 
The expression of the 72 kDa, 65 and 58 kDa polypeptides from mRNA 
transcribed from the eIF-2Ba cDNA was not cap dependent, suggesting that their 
expression may have no in vivo significance. Although, they comigrated with the y 
and 8 subunits of eIF-2B, these eIF-2B subunits are unlikely to be encoded by the 
same mRNA. In yeast, the five genes postulated to encode the subunits of yeast 
eIF-2B have been cloned and sequenced, making it unlikely that a single gene will 
encode three eIF-2B subunits in mammalian cells (72). Moreover, the 65 kDa and 
58 kDa subunit of eIF-2B are both proposed to bind ATP, but 82 kDa does not. 
Since the expression of 72, 65, and 58 kDa polypeptides in vitro is cap independent, 
we suggest that they are due to internal initiation from the eIF-2Ba DNA. The 
observed incorporation of the 12; 65 and 58 kDa polypetide into endogenous eIF-2B 
complex suggests that the amino acid sequences lacking in these polypeptides are 
not necessary for incorporation of eIF-2BB into eIF-2B complex. 
Future Studies 
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The isolation and characterization of eIF-2BB cDNA provides the first primary 
structure of any of the subunits of eIF-2B. This will facilitate the characterization of 
the function of eIF-2B. To facilitate characterization of eIF-2B, accurate knowledge 
of the initiating codon for eIF-2BB cDNA is necessary. This can be accomplished 
by: 
1. Specific mutation of the postulated initiation codon and analysis of the effect of 
the mutation on eIF-2BB expression. 
2. Isolation and analysis of the genomic DNA for eIF-2BB, to obtain its full 5' non 
coding sequence and verify that there is no upstream AUG in frame with its 
translational reading frame. In addition, information will be obtained on possible 
upstream sequences that may be important for the binding of transcription factors 
that regulate eIF-2BB transcription. 
The determination of the residues present in eIF-2BB that are phosphorylated by 
casein kinase II is of great interest. This will require microsequencing of 
radiolabeled peptide fragments obtained from eIF-2BB phosphorylated in the eIF-2B 
complex in vivo and by casein kinase II in vitro. The comparison of the sequences 
of these fragments with the deduced sequence of eIF-2BB could enable the 
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determination of the phosphorylated residues and whether the site phosphorylated by 
casein kinase II in vitro is also phosphorylated in vivo. Determining the 
phosphorylated residues would enable specific mutation(s) to be designed that would 
facilitate determining if phosphorylation actually has a regulatory effect in vivo. 
Expression of eIF-2BE would make larger quantities of the protein available for 
the production of antibodies specific for this subunit. The antibody currently 
available is limited in its usefullness since it recognizes only denatured eIF-2B. 
Production of antibody to eIF-2B is expected to solve this problem and facilitate the 
quantitation of eIF-2B in vivo. 
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